Evaluating the impact of thrombopoietin receptor agonist medications on patient outcomes and quality of life in paediatric immune thrombocytopenia through <scp>semi‐structured</scp> interviews-Reference-Cited by-同舟云学术

Evaluating the impact of thrombopoietin receptor agonist medications on patient outcomes and quality of life in paediatric immune thrombocytopenia through semi‐structured interviews

Published:2022-11-08 Issue:4 Volume:200 Page:506-516
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Livingston Joel¹²^ORCID,Alrajhi Ziyad¹³,Jackson Melanie¹,McGuire Catherine⁴,Newhook Dennis⁴,Klaassen Robert J.⁴,Kirby‐Allen Melanie¹

Affiliation:

1. The Hospital for Sick Children (SickKids) The University of Toronto Toronto Ontario Canada

2. Department of Pediatrics The University of Alberta Alberta Edmonton Canada

3. King Faisal Specialist Hospital and Research Centre Riyadh Saudi Arabia

4. The Children's Hospital of Eastern Ontario (CHEO) The University of Ottawa Ottawa Ontario Canada

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18545

Reference23 articles.

1. Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective

2. Quality of life in immune thrombocytopenia following treatment

3. Updated international consensus report on the investigation and management of primary immune thrombocytopenia

4. Eltrombopag for use in children with immune thrombocytopenia

5. Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life in childhood immune thrombocytopenia: Revision of the Kids' ITP Tools (KIT);British Journal of Haematology;2024-07-27

2. Face validity of the Kids’ ITP Tools (KIT) in the era of thrombopoietin receptor agonists;Pediatric Blood & Cancer;2024-01-24

3. Avatrombopag for severe refractory thrombocytopenia in a pediatric patient with ALL following allogeneic hematopoietic stem cell transplantation: A case report;Leukemia Research Reports;2024

4. Burden of immune thrombocytopenia (ITP): Special considerations for refractory ITP;British Journal of Haematology;2023-09-21

5. Eltrombopag/immune-globulin;Reactions Weekly;2023-08-19